beskrywing van gesondheidsorgdiens wat aan miv-blootgestelde

More documents

Recommendations

Info

Suid-Afrika. Departement van Gesondheid. 2007e. South African National Guidelines on Nutrition for People Living with HIV, AIDS, TB and other Chronic Debilitating Conditions. Pretoria: Government Printer. Suid-Afrika. Departement van Gesondheid. 2007f. South African National Tuberculosis Guidelines. Pretoria: Government Printer. Suid-Afrika. Departement van Gesondheid. 2008. Policy and Guidelines for the Implementation of the PMTCT programme. Pretoria: Government Printer. Suid-Afrika. Departement van Gesondheid. 2009. Criteria for Expedited Antiretroviral (ART) Initiation. Pretoria: [s.n.] Suid-Afrika. Departement van Gesondheid. [n.d.-a] PMTCT Training Guide. Pretoria: Government Printer. The Free Dictionary. 2008. thefreedictionary.com [online]. Available from: http://wwwthefreedictionary.com/caregiver [Accessed on 22 July 2008]. UNAIDS/WHO. 2006. Global Access to HIV Therapy Tripled in Past Two Years, But Significant Challenges Remain [online]. Available from: http://www.who.int/hiv/mediacentre/news57/en/print.html [Accessed on 26 February 2008]. UNAIDS/ WHO, 2007. AIDS Epidemic update. Geneva: UNAIDS, (UNAIDS/07.27E / JC1322E). Uys, H.H.M. & Basson, A.A. 1991. Research Methodology in Nursing. 2 nd ed. Cape Town: Kagiso Tersiary. Van Dyk, A. 2008. HIV/AIDS Care and Counselling. 4 th ed. Cape Town: Pearson Education South Africa. Van Rensburg, H.C.J. (ed.), Benetar, S.R., Doherty, J.E., Heunis, J.C., McIntyre, D.E., Ngwena, C.G., Pelser, A.J., Pretorius, E., Redelinghuys, N. & 211
Summerton, J.V. 2004. Health and Health Care in South Africa. Pretoria: Van Schaik Publishers. Van Rensburg, H.J.C., Steyn, F., Schneider, H. & Loffstadt, L. 2008. Human resource development and antiretroviral treatment in Free State province, South Africa [online]. Available from: http://www.human- resources-health.com/content/6/1/15 [Accessed on 15 September 2009]. Venter, A. 2008. Personal Communication. 02 Junie 2008, Bloemfontein. Verklarende Afrikaanse Woordeboek. 1993. 8 ste uitgawe. Kaapstad: NB-Uitgewers Beperk. Walsh, J.A. & Warren, K.S. 1979. Selective primary health care: an interim strategy for disease control in developing countries. New England Journal of Medicine, 301(18): 967-977, November. Wikipedia. The Free Encyclopedia. 2008. [online]. Available from: http://en.wikipedia.org/wiki/General_practice [Accessed on 26 August 2008]. Woods, D. & Eley, B. 2008. Childhood HIV – A learning programme for professionals. Cape Town: Electric Book Works. Wouters, E., Heunis, C., Van Rensburg, D. & Meulemans, H. 2008. Patient satisfaction with antiretroviral services at primary health-care facilities in the Free State, South Africa – a two year study using four waves of cross-sectional data [online]. Available from: http://www.biomedcentral.com/1472-6963/8/210 [Accessed on 20 August 2009]. Wouters, E., Meulemans, H., Van Rensburg, H.C.J., Heunis, J.C. & Mortelmans, D. 2007. Short-term physical and emotional health outcomes of public sector ART in the Free State province of South Africa [online]. Available from: http://www.springernet.com [Accessed on 12 March 2008]. 212
Page 1 and 2:
BESKRYWING VAN GESONDHEIDSORGDIENS
Page 3 and 4:
VERKLARING Hiermee verklaar ek, dat
Page 5 and 6:
DANKBETUIGINGS Hiermee spreek ek my
Page 7 and 8:
"Do all you can with what you have
Page 9 and 10:
SUMMARY This study was conducted to
Page 11 and 12:
INHOUDSOPGAWE HOOFSTUK 1: Inleiding
Page 13 and 14:
2.4.1.3 Departementele riglyne vir
Page 15 and 16:
v Bladsy 3.7.3 Finalisering van die
Page 17 and 18:
4.4.5 Professionele verpleegkundige
Page 19 and 20:
ix Bladsy FIGUUR 4.10 Kliniese krit
Page 21 and 22:
LYS VAN BYLAE BYLAE A SKRIFTELIKE V
Page 23 and 24:
Aangesien 40% van laasgenoemde ster
Page 25 and 26:
toegang tot behandeling kry nie (Mi
Page 27 and 28:
1.4 KONSEP- EN OPERASIONELE DEFINIS
Page 29 and 30:
Primêre versorger: „n Primêre v
Page 31 and 32:
1.6 NAVORSINGSTEGNIEKE Navorsingste
Page 33 and 34:
TABEL 1.1: Aantal en soort gesondhe
Page 35 and 36:
Die res van die teikenpopulasie slu
Page 37 and 38:
gebruik word om die hoofstudie te o
Page 39 and 40:
Die vraelyste sal voor die aanvang
Page 41 and 42:
gesondheid-sorgfasiliteite te doen,
Page 43 and 44:
2.1. INLEIDING HOOFSTUK 2 LITERATUU
Page 45 and 46:
internasionale gebeurtenisse. Na di
Page 47 and 48:
2.2.1.1 Primêre vlak van sorg Die
Page 49 and 50:
mediese sorg bestaan nie. PGS is di
Page 51 and 52:
“A comprehensive health care syst
Page 53 and 54:
dienslewering op nasionale, provins
Page 55 and 56:
sorg deur super-/sub-spesialiste in
Page 57 and 58:
Kinders betree die gesondheidsorgsi
Page 59 and 60:
2.3.3 Tersiêre gesondheidsorg aan
Page 61 and 62:
2.4.1.1 Operational Plan for Compre
Page 63 and 64:
verskaffing van ART; profilaktiese
Page 65 and 66:
direktorate van die Strategiese Ges
Page 67 and 68:
was ook al enkele gevalle waar geen
Page 69 and 70:
2.4.2.1.1 Primêre voorkoming van M
Page 71 and 72:
wat ter bereiking van hierdie doel
Page 73 and 74:
aanvaarbaar (acceptible), haalbaar
Page 75 and 76:
Voorligting met betrekking tot veil
Page 77 and 78:
PCR-tegniek Die toets word sedert 2
Page 79 and 80:
Identifiseer alle MIV-geïnfekteerd
Page 81 and 82:
2.4.2.2 Vrywillige berading en toet
Page 83 and 84:
die MIV-positiewe persoon se lewens
Page 85 and 86:
Die MIV/VIGS-pandemie het egter die
Page 87 and 88:
TABEL 2.1: Hantering van die twee m
Page 89 and 90:
afspraak word vir vier weke ná die
Page 91 and 92:
geaffekteerde lande in die wêreld
Page 93 and 94:
2.4.2.7 Practical Approach to Lung
Page 95 and 96:
TABEL 2.2: Opsomming van pediatries
Page 97 and 98:
2.5. UITDAGINGS TEN OPSIGTE VAN DIE
Page 99 and 100:
sluit voorgeboortelike sorg, MIV-di
Page 101 and 102:
Michaels et al. (2006:31) het na
Page 103 and 104:
2.6 AFSLUITING Tot op hede was die
Page 105 and 106:
3.2 NAVORSINGSONTWERP In teenstelli
Page 107 and 108:
kan word (Burns & Grove, 2007:240).
Page 109 and 110:
3.4 NAVORSINGSTEGNIEKE Navorsingste
Page 111 and 112:
Die volgende aspek wat 'n nadelige
Page 113 and 114:
Die navorser het gepoog om vraelyst
Page 115 and 116:
hierdie instruksies nie in Tabel 3.
Page 117 and 118:
TABEL 3.2: Aantal en soort gesondhe
Page 119 and 120:
VRYSTAAT PROVINSIE TABEL 3.3: Steek
Page 121 and 122:
Verteenwoordiging beteken dat die s
Page 123 and 124:
aangesien die Vrystaatse DvG nie ak
Page 125 and 126:
tegnieke van onderhoudvoering; die
Page 127 and 128:
studieresultate nadelig kan beïnvl
Page 129 and 130:
3.7.3 Finalisering van die vraelys
Page 131 and 132:
Deelnemer stem in Onderhoudvoering
Page 133 and 134:
navorsing, sowel as die deelnemer s
Page 135 and 136:
Volgens Tabel 3.4 kon die navorser/
Page 137 and 138:
3.10.1 Geldigheid Geldigheid verwys
Page 139 and 140:
gemeet word, is die volgende kompon
Page 141 and 142:
dat iemand met „n persoon in „n
Page 143 and 144:
Grove, 2009:189; Babbie & Mouton, 2
Page 145 and 146:
van data. Aangesien die navorser va
Page 147 and 148:
3.11.4 Wetenskaplike integriteit en
Page 149 and 150:
etrekking gehad het. Bykomend tot h
Page 151 and 152:
VRYSTAAT PROVINSIE in die steekproe
Page 153 and 154:
Volgens Tabel 4.2 was daar 14 hospi
Page 155 and 156:
% 100 75 50 25 0 68 Gemeenskaps ver
Page 157 and 158:
nie kan bekostig om studieverlof vi
Page 159 and 160:
Immunisering (Vaccinator‟s Manual
Page 161 and 162:
PMTCT-opleiding word aan vroedvroue
Page 163 and 164:
wat hierdie dienste besoek, dalk on
Page 165 and 166:
positiewe kinders (SA. DvG, 2005a:
Page 167 and 168:
PALSA-Plus-opgeleide PV‟s hul ken
Page 169 and 170:
(94%) aangedui dat hulle bykomende
Page 171 and 172:
kliniese riglyne wat gevolg word, s
Page 173 and 174:
Tabel 4.3 illustreer verder dat fei
Page 175 and 176:
geen afleiding in hierdie verband g
Page 177 and 178:
% 100 75 50 25 0 48 PMTCT 94 58 VCT
Page 179 and 180:
% 100 75 50 25 0 36 96 FIGUUR 4.6:
Page 181 and 182: 4.3.5 Gesondheidsorg aan MIV-blootg
Page 183 and 184: 'n kind wat aan MIV blootgestel is,
Page 185 and 186: Dieetkundige advies Dieetkundige ad
Page 187 and 188: ehandeling vir helminte toegedien w
Page 189 and 190: verskeie PV‟s aangevoer dat die k
Page 191 and 192: gelewer word, is daar vanweë die t
Page 193 and 194: TABEL 4.7: Behandelingskomponente v
Page 195 and 196: positiewe kinders immuniseer. Die i
Page 197 and 198: MIV-positiewe kind uitsluit nie. An
Page 199 and 200: 4.4 DIENSLEWERING TEN OPSIGTE VAN A
Page 201 and 202: % 100 75 50 25 0 67 Bevestig MIVsta
Page 203 and 204: asislyn-ondersoeke doen. Figuur 4.1
Page 205 and 206: Behalwe vir die beraming van ART-ne
Page 207 and 208: geassosieer word. Al die bogenoemde
Page 209 and 210: % 100 75 50 25 0 60 34 Meer persone
Page 211 and 212: HOOFSTUK 5 AANBEVELINGS EN BEPERKIN
Page 213 and 214: Wat verder uit die studie na vore g
Page 215 and 216: Implementering van riglyne Wat die
Page 217 and 218: sorglewering, waar MIV-blootgesteld
Page 219 and 220: 5.2.3 Finansiële implikasie As gev
Page 221 and 222: BRONVERWYSINGS AIDSbuzz. 2009. Volu
Page 223 and 224: Chopra, M., Daviaud, E., Pattinson,
Page 225 and 226: Vrystaat. Departement van Gesondhei
Page 227 and 228: Kofi, O.G. & Lindsey, J. 2006. Savi
Page 229 and 230: Rabie, H., Marais, B.J. & Cotton, M
Page 231: Suid-Afrika. Departement van Gesond
Page 235 and 236: BYLAE A SKRIFTELIKE VERSOEK: AAN DI
Page 237 and 238: 216
Page 239 and 240: 218
Page 241 and 242: Voetnota: Die studie was deel van '
Page 243 and 244: UNIVERSITEIT VAN DIE VRYSTAAT UNIVE
Page 245 and 246: BYLAE E VRAELYS: GEBRUIK TYDENS GES
Page 247 and 248: 2. Tipe fasiliteit (merk almal van
Page 249 and 250: 4.3 In watter van die volgende PROG
Page 251 and 252: 5.4.2 Indien NEE, wat is die rede(s
Page 253 and 254: 5.7 “Counsel” u persoonlik KIND
Page 255 and 256: 5.11.2 5.12 5.12.1 5.12.2 Indien NE
Page 257 and 258: 5.14 Verskaf u deurlopende sorg aan
Page 259 and 260: 5.15.4 5.16 5.16.1 5.17 Indien NEE,
Page 261 and 262: 5.21.1 5.22 5.22.1 5.22.2 5.23 5.23
Page 263 and 264: 1 Weet nie 43 2 Die geneesheer doen
Page 265 and 266: ASSESSMENT TOOL FOR PAEDIATRIC ANTI
Page 267 and 268: 4. INFORMATION, EDUCATION & COMMUNI
Page 269 and 270: 4.5.1 If YES, please specify your n
Page 271 and 272: 5.5.2 If NO, why do you not treat H
Page 273 and 274: 5.10.2 If NO, why do you not test f
Page 275 and 276: 5.12.3 5.13 5.13.1 5.13.2 If NO, wh
Page 277 and 278: 5.14.2 5.15 If NO, why do you not p
Page 279 and 280: 5.18 How often does the manager of
Page 281 and 282: 5.24 ..............................
Page 283 and 284:
5.27 Do you provide health care to
Page 285:
264
show all

beskrywing van gesondheidsorgdiens wat aan miv-blootgestelde

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?